|
Market Closed -
Nasdaq
16:00:00 2026-08-26 EDT
|
5-day change | 1st Jan Change | ||
| 22.02 USD | +0.18% |
|
+1.29% | -17.77% |
| 08-18 | Barclays Adjusts Price Target on Amphastar Pharmaceuticals to $23 From $20, Maintains Equalweight Rating | MT |
| 08-07 | Amphastar Pharmaceuticals, Inc., Q2 2026 Earnings Call, Aug 06, 2026 |
Stock exchange
Quotes 5-day view: Amphastar Pharmaceuticals, Inc.
Delayed Quote Nasdaq| 2026-08-20 | 2026-08-21 | 2026-08-24 | 2026-08-25 | 2026-08-26 | |
|---|---|---|---|---|---|
| Last | US$21.68 | US$21.60 | US$21.52 | US$21.98 | US$22.02 |
| Volume | 338,697 | 376,558 | 210,263 | 283,774 | 395,570 |
| Change | -0.28% | -0.37% | -0.37% | +2.14% | +0.18% |
| Opening | US$21.38 | US$21.64 | US$21.60 | US$21.50 | US$21.86 |
| High | US$21.76 | US$22.20 | US$21.81 | US$22.07 | US$22.44 |
| Low | US$21.24 | US$21.44 | US$21.26 | US$21.41 | US$21.72 |
Performance
| 1 day | +0.18% | ||
| 1 week | +1.29% | ||
| Current month | +10.43% | ||
| 1 month | +17.63% | ||
| 3 months | +17.07% | ||
| 6 months | -16.87% | ||
| Current year | -17.77% | ||
| 1 year | -27.42% | ||
| 3 years | -58.45% | ||
| 5 years | +16.51% | ||
| 10 years | +13.27% |
Volumes
marketsDaily volume
395,610
Estimated daily volume
395,610
Avg. Volume 20 sessions
475,819
Daily volume ratio
0.83
Avg. Volume 20 sessions USD
10,477,534.38
Record volume 1
6,087,485
Record volume 2
4,284,712
Record volume 3
3,279,268
Capital turnover ratio
0.01
Float rotation
0.02
Basic data
Market Cap (USD)
934,984,009
Net sales (USD)
719,887,000
Number of employees
1,976
Sales / Employee (USD)
364,315
Free-Float
47.23 %
Free-Float capitalization (USD)
646,806,361
Average Daily Capital Traded
1.12%
Indicators
Moving average 5 days
21.76
Moving average 20 days
20.72
Moving average 50 days
20.07
Moving average 100 days
20.15
Price spread / (MMA5)
-1.18%
Price spread / (MMA20)
-5.91%
Price spread / (MMA50)
-8.86%
Price spread / (MMA100)
-8.49%
STIM
RSI 9 days
70.12
RSI 14 days
64.72
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| +0.18% | +1.29% | -27.42% | -58.45% | 935M | ||
| -3.59% | -7.10% | +61.60% | +114.83% | 1,100B | ||
| -1.15% | -1.25% | +52.98% | +62.41% | 658B | ||
| -1.09% | -1.15% | +26.18% | +79.22% | 470B | ||
| -1.47% | +0.24% | +42.09% | +42.09% | 372B | ||
| -0.90% | +0.05% | +25.57% | +41.75% | 304B | ||
| -1.94% | +1.53% | +3.05% | +13.24% | 264B | ||
| -0.43% | -0.46% | +52.06% | +71.75% | 239B | ||
| -0.93% | +1.84% | -13.11% | -52.28% | 213B | ||
| -0.46% | +0.33% | +29.05% | +92.67% | 184B | ||
| Average | -1.18% | +0.28% | +25.21% | +40.72% | 380.38B | |
| Weighted average by Cap. | -1.82% | -1.58% | +40.52% | +68.21% |
Historical Quotes: Amphastar Pharmaceuticals, Inc.
| Date | Opening | High | Low | Close | Volume | Change |
|---|
Latest transactions
a40e134e460df98a0d64588.dhsFjb_0C0wHyy6fI4C_ovim08cn2vBKf6gHj-ilz6g.PERX3c6mRjt2qXjaZ876247q6o1SkoAbN9tiypLdupw6az26iKZvG1iiZw
| Date | Price | Volume | Total |
|---|---|---|---|
| 16:00:00 | 22.02 | 95,847 | 265,644 |
| 15:59:58 | 22.01 | 100 | 169,797 |
| 15:59:54 | 22.02 | 180 | 169,697 |
| 15:59:50 | 22.03 | 100 | 169,517 |
| 15:59:50 | 22.03 | 100 | 169,417 |
| 15:59:47 | 22.03 | 100 | 169,317 |
| 15:59:46 | 22.02 | 100 | 169,217 |
| 15:59:46 | 22.03 | 532 | 169,117 |
| 15:59:46 | 22.03 | 100 | 168,585 |
| 15:59:45 | 22.04 | 100 | 168,485 |
Price Extremes
| 1 week | 21.26 | 22.44 | |
| 1 month | 19.38 | 22.64 | |
| Current year | 16.64 | 29.52 | |
| 1 year | 16.64 | 31.26 | |
| 3 years | 16.64 | 65.92 | |
| 5 years | 16.64 | 67.66 | |
| 10 years | 12.05 | 67.66 |
Monthly variations
Annual variations
| 2026 | -17.77% | ||
| 2025 | -27.88% | ||
| 2024 | -39.97% | ||
| 2023 | +120.74% | ||
| 2022 | +20.31% | ||
| 2021 | +15.81% | ||
| 2020 | +4.25% | ||
| 2019 | -3.07% | ||
| 2018 | +3.43% | ||
| 2017 | +4.45% | ||
| 2016 | +29.44% | ||
| 2015 | +22.57% | ||
| 2014 | +15.98% |
- Stock Market
- Stocks
- AMPH Stock
- Quotes Amphastar Pharmaceuticals, Inc.
Select your edition
All financial news and data tailored to specific country editions

















